Construction of in vitro liver-on-a-chip models and application progress

被引:0
|
作者
Jie Liu
Yimei Du
Xinxin Xiao
Daopeng Tan
Yuqi He
Lin Qin
机构
[1] Zunyi Medical University,Guizhou Engineering Research Center of Industrial Key
[2] Zunyi Medical University,Technology for Dendrobium Nobile, School of Pharmacy
[3] The Second Affiliated Hospital of Zunyi Medical University,Joint International Research Laboratory of Ethnomedicine of Ministry of Education
来源
BioMedical Engineering OnLine | / 23卷
关键词
Liver; Liver-on-a-chip; Hepatotoxicity tests; Disease modeling; Drug screening; Chip combinations;
D O I
暂无
中图分类号
学科分类号
摘要
The liver is the largest internal organ of the human body. It has a complex structure and function and plays a vital role in drug metabolism. In recent decades, extensive research has aimed to develop in vitro models that can simulate liver function to demonstrate changes in the physiological and pathological environment of the liver. Animal models and in vitro cell models are common, but the data obtained from animal models lack relevance when applied to humans, while cell models have limited predictive ability for metabolism and toxicity in humans. Recent advancements in tissue engineering, biomaterials, chip technology, and 3D bioprinting have provided opportunities for further research in in vitro models. Among them, liver-on-a-Chip (LOC) technology has made significant achievements in reproducing the in vivo behavior, physiological microenvironment, and metabolism of cells and organs. In this review, we discuss the development of LOC and its research progress in liver diseases, hepatotoxicity tests, and drug screening, as well as chip combinations. First, we review the structure and the physiological function of the liver. Then, we introduce the LOC technology, including general concepts, preparation materials, and methods. Finally, we review the application of LOC in disease modeling, hepatotoxicity tests, drug screening, and chip combinations, as well as the future challenges and directions of LOC.
引用
收藏
相关论文
共 41 条
  • [31] Innovative organotypic in vitro models for safety assessment: aligning with regulatory requirements and understanding models of the heart, skin, and liver as paradigms
    Chris S. Pridgeon
    Constanze Schlott
    Min Wei Wong
    Minne B. Heringa
    Tobias Heckel
    Joe Leedale
    Laurence Launay
    Vitalina Gryshkova
    Stefan Przyborski
    Rachel N. Bearon
    Emma L. Wilkinson
    Tahera Ansari
    John Greenman
    Delilah F. G. Hendriks
    Sue Gibbs
    James Sidaway
    Rowena L. Sison-Young
    Paul Walker
    Mike J. Cross
    B. Kevin Park
    Chris E. P. Goldring
    Archives of Toxicology, 2018, 92 : 557 - 569
  • [32] A 3D bio-printed spheroids based perfusion in vitro liver on chip for drug toxicity assays
    Tian, Tian
    Ho, Yuhan
    Chen, Chen
    Sun, Hebin
    Hui, Janan
    Yang, Panhui
    Ge, Yuqing
    Liu, Ting
    Yang, Jian
    Mao, Hongju
    CHINESE CHEMICAL LETTERS, 2022, 33 (06) : 3167 - 3171
  • [33] Progress towards the clinical application of helper-dependent adenoviral vectors for liver and lung gene therapy
    Brunetti-Pierri, Nicola
    Ng, Philip
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2006, 8 (05) : 446 - 454
  • [34] Computational reconstruction of tissue-specific metabolic models: application to human liver metabolism
    Jerby, Livnat
    Shlomi, Tomer
    Ruppin, Eytan
    MOLECULAR SYSTEMS BIOLOGY, 2010, 6
  • [35] Strategies for Deliberate Induction of Immune Tolerance in Liver Transplantation: From Preclinical Models to Clinical Application
    Tanimine, Naoki
    Ohira, Masahiro
    Tahara, Hiroyuki
    Ide, Kentaro
    Tanaka, Yuka
    Onoe, Takashi
    Ohdan, Hideki
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [36] Development and Application of a Transcriptomic Signature of Bioactivation in an Advanced In Vitro Liver Model to Reduce Drug-induced Liver Injury Risk Early in the Pharmaceutical Pipeline
    Kang, Wen
    Podtelezhnikov, Alexei A.
    Tanis, Keith Q.
    Pacchione, Stephen
    Su, Ming
    Bleicher, Kimberly B.
    Wang, Zhibin
    Laws, George M.
    Griffiths, Thomas G.
    Kuhls, Matthew C.
    Chen, Qing
    Knemeyer, Ian
    Marsh, Donald J.
    Mitra, Kaushik
    Lebron, Jose
    Sistare, Frank D.
    TOXICOLOGICAL SCIENCES, 2020, 177 (01) : 121 - 139
  • [37] Studying non-alcoholic fatty liver disease: the ins and outs of in vivo, ex vivo and in vitro human models
    Green, Charlotte J.
    Parry, Sion A.
    Gunn, Pippa J.
    Ceresa, Carlo D. L.
    Rosqvist, Fredrik
    Piche, Marie-Eve
    Hodson, Leanne
    HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2020, 41 (01)
  • [38] Application of Gelatin Bioinks and Cell-Printing Technology to Enhance Cell Delivery Capability for 3D Liver Fibrosis-on-a-Chip Development
    Lee, Hyungseok
    Kim, Jongmin
    Choi, Yeongjin
    Cho, Dong-Woo
    ACS BIOMATERIALS SCIENCE & ENGINEERING, 2020, 6 (04): : 2469 - 2477
  • [39] Preclinical exploration of combined glucagon inhibition and liver-preferential insulin for treatment of diabetes using in vitro assays and rat and mouse models
    Hvid, Henning
    Brand, Christian L.
    Hummelshoj, Tina
    Jensen, Sanne
    Bouman, Stephan D.
    Bowler, Andrew
    Poulsen, Bjarne R.
    Tiainen, Peter
    Akertrom, Thorbjorn
    Demozay, Damien
    Hoeg-Jensen, Thomas
    Ingvorsen, Camilla
    Pedersen, Thomas A.
    McGuire, Jim
    Egebjerg, Thomas
    Cappelen, Karen A.
    Eliasen, Ina P.
    Hansen, Bo F.
    Hennen, Stephanie
    Stidsen, Carsten E.
    Olsen, Grith S.
    Roed, Nikolaj K.
    DIABETOLOGIA, 2023, 66 (02) : 376 - 389
  • [40] Preclinical exploration of combined glucagon inhibition and liver-preferential insulin for treatment of diabetes using in vitro assays and rat and mouse models
    Henning Hvid
    Christian L. Brand
    Tina Hummelshøj
    Sanne Jensen
    Stephan D. Bouman
    Andrew Bowler
    Bjarne R. Poulsen
    Peter Tiainen
    Thorbjörn Åkertröm
    Damien Demozay
    Thomas Hoeg-Jensen
    Camilla Ingvorsen
    Thomas Å. Pedersen
    Jim McGuire
    Thomas Egebjerg
    Karen A. Cappelen
    Ina P. Eliasen
    Bo F. Hansen
    Stephanie Hennen
    Carsten E. Stidsen
    Grith S. Olsen
    Nikolaj K. Roed
    Diabetologia, 2023, 66 : 376 - 389